As the introduction of HAART had a significant effect on the median survival of PML patients in HIV population, it is likely that changes in HAART initiation regardless of CD4 count will further improve the prognosis of PML. The gene discussed is CD4; the disease is progressive multifocal leukoencephalopathy.